Wordt geladen...
KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
BACKGROUND: Mutations in the KRAS gene are one of the most frequent genetic abnormalities in ovarian carcinoma. They are of renewed interest as new epidermal growth factor receptor (EGFR)-targeted therapies are being investigated for use in ovarian carcinoma. As KRAS mutations are associated with po...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2671522/ https://ncbi.nlm.nih.gov/pubmed/19358724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-111 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|